01468nas a2200481   4500000000100000000000100001000000100002008004100003653001100044653000900055653003100064653002300095653001200118653001800130653002400148653001700172653002100189653002200210653001700232653003600249653007600285653007500361653008500436653007800521100001400599700001400613700001600627700001400643700001900657700001400676700001500690700001500705700001200720700001300732700001600745700001300761700001200774245015600786250001500942300000800957490000700965020001400972       2023                            d10aHumans10aAged10a*Electronic Health Records10a*Medication Review10aEngland10aPrescriptions10aPrimary health care10apolypharmacy10ageneral practice10aMedication Review10aOlder Adults10aRoutinely Collected Health Data10aResearch (NIHR) School for Primary Care Research (all), NIHR Nottingham10aBiomedical Research Centre (RMJ, RHJ, CACC), and NIHR MindTech MedTech10aCo-operative (DB, LW). AJA is National Clinical Director for Prescribing for NHS10aEngland. All other authors declare that they have no competing interests.1 aR. Joseph1 aR. Knaggs1 aC. Coupland1 aA. Taylor1 aY. Vinogradova1 aD. Butler1 aL. Gerrard1 aD. Waldram1 aB. Iyen1 aR. Akyea1 aD. Ashcroft1 aA. Avery1 aR. Jack00aFrequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records  a2023/07/14  a4350 v23  a1471-2318